Co-financed by

Project No. ALG-02-0853-FEDER-070627

Project Title:
Implementation of an Industrial Unit for Processing the Cannabis Sativa Plant into Products with Medicinal Purposes

Region of Intervention:
PO Algarve

Beneficiary Entity:
CANNPRISMA – PHARMA, LDA

Approval Date Start Date Completion Date
2021-05-06 2020-06-15 2022-06-14

Total Eligible Cost:
€7,197,354.76

European Union Financial Support:
€2,159,206.43

Project Description:
The CANNPRISMA project consists of the creation of an industrial unit for the processing and transformation of the Cannabis Sativa plant for medicinal purposes, aimed at the commercialization of dehydrated flower and flower oil in international markets.

The investments planned in this project embody the following main objectives:
Enable CANNPRISMA to process and transform the cannabis plant for supply to the pharmaceutical industry.

Enable CANNPRISMA to produce more than one type of product.

Enhance the investment to have controlled production costs.

Export to various markets and diverse clients.

Track and control all company activities in a single ERP for production planning, necessary materials and raw materials, and estimated daily productivity, and implement a Business Intelligence system.